San Diego-based Sequenom, the developer of life sciences and genetic testing equipment, said today that it has added Myla Lai-Goldman, M.D., to its board of directors. Lai-Goldman is Managing Partner at Personalized Science LLC, CEO of GeneCentric Diagnostics, and also serves as a Venture Partner at Hatteras Venture Partners.